Clinical Trial Update: An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen [Phase 2]

View source ↗

Summary

This Phase 2 open-label trial compared the bleeding profile of an extended-regimen Norelgestromin/Ethinyl Estradiol regimen with that of a traditional regimen, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metrorrhagia

Drugs mentioned

• Norelgestromin/Ethinyl Estradiol (norelgestromin/ethinyl estradiol)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Metrorrhagia | Phase 2 | Status: COMPLETED